Dear MPN Voice community We are inviting people living with Polycythaemia Vera (PV), Essential Thrombocythaemia (ET), or Myelofibrosis (MF) who have received treatment with interferons (Pegasys or BESREMi) to take part in a short, anonymous survey. This important study aims to gather patient experiences during the recent international interferon shortages. The findings will help inform…
Pegylated Interferon Alpha – Supply & Commissioning Update We are very pleased to let you know that the recent shortage of Pegasys interferon has now been resolved, and hospitals are beginning to receive normal supplies again. While Pegasys was in short supply, some people were prescribed a different interferon called Besremi to make sure treatment…
Take part in a pharmaceutical market research study on the myelofibrosis patient journey About this study The study is sponsored and funded by a pharmaceutical company. MPN Voice have been paid for their consultancy work to contribute to the design of the market research and help with recruiting eligible participants. The study, conducted by Ipsos,…